Outcomes of Transcatheter Aortic Valve Implantation Comparing Medtronic's Evolut PRO and Evolut R: A Systematic Review and Meta-Analysis of Observational Studies.

Mirosław GozdekLukasz Kuzma Emil Julian DąbrowskiMichał JaniakMartyna PietrzakKarolina SkoniecznaMikołaj WoźnicaLidia WydeheftMaged Makhoul Matteo MatteucciRadosław LitwinowiczAdam Kowalówka Wojciech WańhaMichał PasierskiDaniele RoncoGiulio MassimiFederica JiritanoDario FinaGennaro MartucciGiuseppe Maria RaffaPiotr SuwalskiRoberto LorussoPaolo MeaniMariusz Kowalewskinull null

Published in: International journal of environmental research and public health (2023)

The evidence shows good short-term outcomes of both the Evolut PRO and Evolut R prostheses, with no differences in clinical and procedural endpoints. The Evolut PRO was associated with a lower rate of moderate-to-severe PVL and major bleeding.

Keyphrases

transcatheter aortic valve implantation
aortic valve replacement
aortic valve
aortic stenosis
anti inflammatory
transcatheter aortic valve replacement
ejection fraction
early onset
heart failure
type diabetes
high intensity
metabolic syndrome
weight loss